Navigation Links
Icahn Indicates That Biogen Board Refuses To Close Polls
Date:6/3/2009

NEW YORK, June 3 /PRNewswire/ -- Carl Icahn announced today that Biogen is acting in its usual shareholder unfriendly way by manipulating the annual meeting of shareholders in order the prevent the votes that have been submitted from being counted. They are doing so in order to attempt to keep two of the Icahn nominees from winning seats on the Board. If the Board is successful, Richard Mulligan, a prominent scientist and physician, may be kept from legitimately being elected to the Board. This is a consistent theme of this Board. Do everything possible to keep shareholders from entering into the Board's private club to ensure that shareholders are kept in the dark about what the Board is doing, just as they were about last year's sale process. Mr. Icahn concluded that "shareholders should demand that this Board finally act in their interest instead of just attempting to relect themselves. There is absolutely no reason to adjourn the meeting for hours in order to keep the polls open. Do not let them get away with hijacking the election."


'/>"/>
SOURCE Carl Icahn
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amylin Issues Statement in Response to Carl Icahn
2. Icahn Asks Amylin to Allow Discussions With Eastbourne
3. Icahn Responds to Cornelius
4. Icahn Confirms Intention to Nominate Three Directors at Biogen
5. Baseline Research Indicates High Interest in Centocor-Ortho Biotechs SIMPONI(R)
6. New study indicates smallpox vaccination effective for decades
7. New study indicates smallpox vaccination effective for decades
8. Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias
9. Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
10. New Independent Research Study Indicates That Cylexs ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection
11. Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... CA (PRWEB) July 23, 2014 ... cell therapy in the US aimed at improving the ... their newest clinical study for Parkinson’s disease. StemGenex ... of stem cell therapy are paramount when providing care ... clinical study makes stem cell therapy accessible to the ...
(Date:7/23/2014)... Iowa (PRWEB) July 23, 2014 DuPont ... the business as vice president of Agricultural Biotechnology (ABT), ... Biotechnology where he served most recently as president, chief ... biotechnology and business leadership in the seed and crop ... said Paul E. Schickler , president of DuPont ...
(Date:7/23/2014)... , July 23, 2014 regulated information ... research and development pipeline with positive topline results ... brivaracetam . This study was designed to evaluate the ... and 200 mg/day, without titration) compared to placebo, ... with partial-onset seizures, not fully controlled despite treatment ...
(Date:7/23/2014)... VEGAS , July 23, 2014  GrowBLOX Sciences, Inc. ... today that it is filing for two medical marijuana dispensary ... locations are in addition to the Clark County, ... a special use permit, as previously announced.  GrowBLOX ... to be submitting two new applications for dispensaries in the ...
Breaking Biology Technology:StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 2GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 3
... Jan. 29 ChemDiv, Inc., a leading,chemistry-driven ... it has entered into a discovery collaboration ... its expertise in medicinal and synthetic,chemistry, ChemDiv ... antibacterial compounds. Financial terms of the collaboration ...
... (Nasdaq: ALTH ), a biopharmaceutical company focused ... for,the treatment of cancer, today announced that members ... overview at the 2008 Merrill,Lynch Global Pharmaceutical, Biotechnology ... Company,s presentation will take place at 11:00 a.m. ...
... Jan. 29 Edwards Lifesciences,Corporation (NYSE: EW ), ... announced that it has received conditional approval from the ... to the U.S. pivotal,clinical trial of the Edwards SAPIEN ... of the Ascendra transapical,delivery system to the trial, and ...
Cached Biology Technology:ChemDiv and Achaogen Enter Into a Discovery Collaboration 2Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference 2Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve 2Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve 3
(Date:7/23/2014)... , , , , , , , , ... , , , , , ... researchers are proposing that changing how medical care is delivered could help prevent multiple chronic diseases and extend healthy lifespan. The idea, they argue, would be ... , , , , , ... , , , , , ...
(Date:7/23/2014)... its grip is affecting more than the color of people,s ... a heat-loving amoeba commonly found in warm freshwater bodies, such ... made warmer than usual this year. , A 9-year-old Kansas ... after swimming in several area lakes. The amoeba enters the ... the brain. Nose plugs can lower the odds of this ...
(Date:7/23/2014)... soil releases about 60 billion tons of carbon into ... that released by burning fossil fuels. This happens through ... carbon is balanced by carbon coming into the soil ... well as by the underground activities of plant roots. ... temperatures increase the rate of soil respiration. As a ...
Breaking Biology News(10 mins):Strategy proposed for preventing diseases of aging 2Strategy proposed for preventing diseases of aging 3Strategy proposed for preventing diseases of aging 4Strategy proposed for preventing diseases of aging 5Diseases of another kind 2Climate change and the soil 2
... Wildlife Conservation Society and the State Institute of Animal Health ... of the first health assessments of white-lipped peccaries (medium-sized pig-like ... gauge the impact of Leptospirosis a zoonotic bacteria that ... wildlife and livestock. The studyconducted between 2003 and ...
... HAMILTON, ON (March 23, 2011) - A lot of chatter ... of it happens between our ears. Researchers at McMaster ... and our brain plays an important role in the development ... as well including obesity. "The wave of the future ...
... Researchers at Rice University have created a synthetic ... the body strengthens bones and muscles after repeated workouts. ... professor in mechanical engineering and materials science and of ... carbon nanotube fillers. The team reported its discovery this ...
Cached Biology News:Monitoring peccaries in Brazil benefits wildlife, local communities and food security 2Monitoring peccaries in Brazil benefits wildlife, local communities and food security 3'Knowing it in your gut' is real 2Rice University lab creates self-strengthening nanocomposite 2Rice University lab creates self-strengthening nanocomposite 3
Homo sapiens inhibin, beta B (activin AB beta polypeptide) Antigen: Recombinant Protein(142~254aa)...
Self Closing Forceps...
Mouse IL-31 RA Biotinylated Affinity Purified PAb...
... 1 outflow Single-cell and patch delivery ... solution change Very small dead volume , ... 360, 250 and 100 micron delivery tips ... micromanipulator Available in 4, 8, and 16 ...
Biology Products: